{
    "organizations": [],
    "uuid": "7b54f03b5e6ea7376a239f9bf254a2fd7d1c1c50",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-morphosys-says-tremfya-approved-to/brief-morphosys-says-tremfya-approved-to-treat-psoriasis-in-japan-idUSFWN1RI0TA",
    "ord_in_thread": 0,
    "title": "BRIEF-Morphosys Says Tremfya Approved To Treat Psoriasis In Japan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 6 (Reuters) - MorphoSys AG:\n* SAYS ANNOUNCES APPROVAL OF TREMFYA(R) (GUSELKUMAB) FOR THE TREATMENT OF MODERATE TO SEVERE FORMS OF PSORIASIS AND PSORIATIC ARTHRITIS IN JAPAN Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-06T13:35:00.000+03:00",
    "crawled": "2018-04-07T16:21:55.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "morphosys",
        "ag",
        "say",
        "announces",
        "approval",
        "tremfya",
        "r",
        "guselkumab",
        "treatment",
        "moderate",
        "severe",
        "form",
        "psoriasis",
        "psoriatic",
        "arthritis",
        "japan",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}